In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amorfix Life Sciences Ltd.

www.amorfix.com

Latest From Amorfix Life Sciences Ltd.

Alzheimer’s Disease: Moving Toward The Era Of Diagnostic Certainty

With more than 13 million people in the US expected to have Alzheimer’s disease (AD) by 2050, an increasing number of companies are focused on developing reliable AD diagnostics designed to facilitate early detection and treatment. Although the field remains in its relative infancy, researchers are gaining greater diagnostic certainty through a combination of diagnostic approaches, and over the next decade, the AD diagnostics market is projected to reach a US market value of at least $1 billion to $3 billion per year.

Medical Device Innovation

Amorfix appoints Warren Whitehead CFO

Warren Whitehead

Medical Device Deals Update, August 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Deals Shaping The Medical Industry, July-August 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Amorfix Life Sciences Ltd.
  • Senior Management
  • Robert Gundel, PhD, Pres. & CEO
    Janet Clennett, Acting CFO
    Lynda Covello, VP, Strategic Alliances
    Neil Cashman, PhD, CSO
  • Contact Info
  • Amorfix Life Sciences Ltd.
    Phone: (416) 847-6898
    3403 American Dr.
    Mississauga, L4V 1T4
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register